Invivyd (IVVD) Cash from Financing Activities (2021 - 2025)

Invivyd (IVVD) reported Cash from Financing Activities of $157.2 million for Q4 2025, up 204025.97% on a YoY basis from N/an in Q4 2024, and up 169.54% quarter-over-quarter from $58.3 million in Q3 2025.

Invivyd (IVVD) Cash from Financing Activities (2021 - 2025) Analysis & Trends

Invivyd has reported Cash from Financing Activities for 5 years, with the latest figure at $157.2 million in Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities rose 204025.97% year-over-year to $157.2 million; the trailing twelve-month figure through Dec 2025 stood at $215.6 million (up 448.24% YoY), and the FY2025 full-year result was $215.6 million, up 448.24% from the prior year.
  • Cash from Financing Activities for Q4 2025 stood at $157.2 million, up from $58.3 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $334.8 million in Q2 2021, with the low at -$749000.0 in Q4 2021.
  • Historically, Cash from Financing Activities has averaged $48.4 million across 5 years, with a median of $141000.0 in 2022.
  • Annual changes were most pronounced in 2022 — Cash from Financing Activities plunged 99.98% — and 2025, when it jumped 204025.97%.
  • Invivyd's Cash from Financing Activities stood at -$749000.0 in 2021, then surged by 118.83% to $141000.0 in 2022, then changed by 0.0% to $141000.0 in 2023, then plunged by 45.39% to $77000.0 in 2024, then jumped by 204025.97% to $157.2 million in 2025.
  • The last three Cash from Financing Activities figures came in at $157.2 million (Q4 2025), $58.3 million (Q3 2025), and $131000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 Invivyd 168.41 Mn -58.28 Mn - 157.18 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 157.18 Mn
Dec 31, 2025 157.18 Mn
Sep 30, 2025 58.31 Mn
Sep 30, 2025 58.31 Mn
Jun 30, 2025 131,000.00
Jun 30, 2025 131,000.00
Mar 31, 2025 10,000.00
Mar 31, 2025 10,000.00
Dec 31, 2024 77,000.00
Dec 31, 2024 77,000.00
Sep 30, 2024 61,000.00
Sep 30, 2024 61,000.00
Jun 30, 2024 92,000.00
Jun 30, 2024 92,000.00
Mar 31, 2024 39.10 Mn
Mar 31, 2024 39.10 Mn
Dec 31, 2023 141,000.00
Dec 31, 2023 141,000.00
Sep 30, 2023 92,000.00
Sep 30, 2023 92,000.00